Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Empagliflozin by Boehringer Ingelheim International for Renal Stones/Calculi: Likelihood of Approval
Empagliflozin is under clinical development by Boehringer Ingelheim International and currently in Phase II for Renal Stones/Calculi. According to GlobalData,...
Empagliflozin by Boehringer Ingelheim International for Pulmonary Arterial Hypertension: Likelihood of Approval
Empagliflozin is under clinical development by Boehringer Ingelheim International and currently in Phase II for Pulmonary Arterial Hypertension. According to...
Empagliflozin by Boehringer Ingelheim International for Chronic Kidney Disease (Chronic Renal Failure): Likelihood of Approval
Empagliflozin is under clinical development by Boehringer Ingelheim International and currently in Phase III for Chronic Kidney Disease (Chronic Renal...